A Pilot Open-Label Clinical Trial of CPI-613 in Patients With Advanced Bile Duct Cancers
Phase of Trial: Phase I/II
Latest Information Update: 16 May 2019
At a glance
- Drugs CPI 613 (Primary)
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- 28 Sep 2018 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Planned End Date changed from 1 Aug 2018 to 1 Oct 2018.
- 22 May 2018 Status changed from recruiting to active, no longer recruiting.